Hemostats for Sale 2018-2024: Global Market Insights, Size, Industry Growth Rate, Regional Outlook, Key Companies Ethicon US LLC, Pfizer and C.R. Bard Inc.

Hemostats Market with figures as recent as 2018 and forecasts up to 2024 provides an overview of the industry including its definition, size, share, growth, applications and manufacturing technology.

Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-hemostats-market

Key Points: Global Hemostats Market

Ethicon US LLC (U.S.) is dominating the hemostats market followed by Pfizer and C.R. Bard Inc., along with others such as Baxter, Vascular Solutions, Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company), Anika Therapeutics, Inc., Arch Therapeutics Inc., Biom’Up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., Hemostasis, LLC, MedTrade Products Limited, Integra LifeSciences Corporation, Medline Industries, Inc., HEMOTEC MEDICAL GMBH, Stryker, CSL Behring, Mallinckrodt, and Equimedical, B.V. among other companies.

Combination agents market is growing with the highest CAGR.

Thrombin based hemostats is driving the market with the highest market share.

Surgery is dominating the application segment in the hemostats market.

Get 10% Discount Instant Mail us @ sopan.gedam@databridgemarketresearch.com

Market Segmentation: Global Hemostats Market

The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user. The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based hemostats, gelatin based hemostats and collagen based hemostats. In 2017, the thrombin based hemostats segment is expected to dominate the market with a share of ~38.0% and collagen agents is expected to grow with the highest CAGR during the forecast period from 2017 to 2024.

On the basis of application, the market is segmented into surgery and wound closure.

On the basis of end users, the market is classified into hospitals, community healthcare, ambulatory centres and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Inquiry Before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hemostats-market

Key Drivers: Global Hemostats Market

Some of the major factors driving the market for hemostats market are increasing number of surgeries, technological advancement, increasing healthcare expenditure and infrastructure. These factors are increasing the demand for different hemostatic agents.

Reluctance of surgeons towards new products may hinder the growth of this market.

The weak reimbursement scenario will hamper the growth of the market for new and innovative therapies or hemostats products, causing companies to withdraw from the market thus increasing the hospital costs putting all burdens onto the patient for treatment.

Report Analysis:

Global Hemostats Market is expected to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

View Full Report @ http://databridgemarketresearch.com/reports/global-hemostats-market/

Table of Contents:

1. INTRODUCTION

1.1. OBJECTIVES OF THE STUDY
1.2. MARKET DEFINITION
1.3. OVERVIEW OF GLOBAL HEMOSTATS MARKET
1.4. CURRENCY AND PRICING
1.5. LIMITATION
1.6. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCE
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.2. RESTRAINTS

3.3. OPPORTUNITIES

3.4. CHALLENGES

4. PREMIUM INSIGHTS

5. REGULATORY

5.1. OVERVIEW
5.2. REGULATORY PROCEDURE

6. REIMBURSEMENT

6.1. OVERVIEW
6.2. REIMBURSEMENT SCENARIO

7. EXECUTIVE SUMMARY

8. GLOBAL HEMOSTATS MARKET, BY TYPE

8.1. OVERVIEW
8.2. THROMBIN BASED HEMOSTATS
8.3. COMBINATION AGENT HEMOSTATS
8.4. OXIDIZED REGENERATED CELLULOSE BASED HEMOSTATS
8.5. GELATIN BASED HEMOSTATS
8.6. COLLAGEN BASED HEMOSTATS

9. GLOBAL HEMOSTATS MARKET,BY APPLICATION

9.1. OVERVIEW
9.2. GLOBAL HEMOSTATS MARKET, BY APPLICATION
9.3. WOUND CLOSURE
9.4. SURGICAL HEMOSTATS

10. GLOBAL HEMOSTATS MARKET, BY DISTRIBUTION CHANNEL

10.1. OVERVIEW

11. GLOBAL HEMOSTATS MARKET, BY END USER

11.1. OVERVIEW
11.2. HOSPITALS
11.3. AMBULATORY CENTERS
11.4. COMMUNITY HEALTHCARE
11.5. CLINICS

12. GLOBAL HEMOSTATS MARKET, BY GEOGRAPHY

12.1. OVERVIEW

12.2. NORTH AMERICA

12.3. EUROPE

12.4. ASIA-PACIFIC (APAC)

12.5. SOUTH AMERICA

12.6. MEA

13. GLOBAL HEMOSTATS MARKET, COMPANY LANDSCAPE

13.1. COMPANY SHARE ANALYSIS: GLOBAL
13.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3. COMPANY SHARE ANALYSIS: EUROPE
13.4. COMPANY SHARE ANALYSIS: APAC

14. COMPANY PROFILES

14.1. ETHICON US, LLC (SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC)

14.2. PFIZER

14.3. C.R BARD

14.4. BAXTER

14.5. VASCULAR SOLUTIONS, INC (ACQUIRED BY TELEFLEX INCORPORATED)

14.6. B.BRAUN MELSUNGEN AG

14.7. 3-D MATRIX LTD

14.8. RESORBA MEDICAL GMBH

14.9. ANIKA THERAPEUTICS, INC.

14.10. BIOM’UP

14.11. CRYOLIFE, INC.

14.12. EQUIMEDICAL

14.13. HEMOSTASIS, LLC

14.14. MEDTRADE PRODUCTS LIMITED

14.15. STRYKER

14.16. ARCH THERAPEUTICS, INC.

14.17. INTEGRA LIFESCIENCES CORPORATION

14.18. ALTAYLAR MEDICAL

14.19. BIOCER ENTWICKLUNGS-GMBH

14.20. SMI (STARCH MEDICAL)

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.